Moderna (MRNA)

SG&A Expense Growth

24.86%

Quarterly · Period ending:

MRNA logo

MRNA SG&A Expense Growth

Latest reported24.86%
MRNA Quarterly SG&A Growth (QoQ) (0.00% → 24.86%)
High-resolution chart · PNG

MRNA sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
24.8555%
-43.8312%
14.9254%
16.5217%
8.4906%
-39.6011%
24.911%
4.8507%
-2.1898%
-41.7021%
6.3348%
33.1325%
8.8525%
-18.6667%
34.8921%
31.7536%
-21.2687%
33.3333%
19.6429%
38.843%
57.1429%
-2.5193%
64.5625%
29.7297%
53.4378%
-5.9003%
-9.089%
-1.1745%
4.545%
-28.2461%
105.2524%
-13.382%
31.0719%
2.5904%
-4.9313%
4.279%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.